Bedford, MA, United States of America

Lyubomir Vassilev

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lyubomir Vassilev. Retrieved from https://idiyas.com/inventor/lyubomir-vassilev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Lyubomir Vassilev

Introduction

Lyubomir Vassilev is a notable inventor based in Bedford, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work primarily focuses on the combination of therapeutic agents to enhance treatment efficacy.

Latest Patents

Lyubomir Vassilev holds a patent for a groundbreaking invention titled "Combination of a protein kinase inhibitor and an additional chemotherapeutic agent - Combination therapy for the treatment of cancer." This patent represents a significant advancement in cancer therapy, aiming to improve patient outcomes through combined treatment strategies. He has 1 patent to his name.

Career Highlights

Vassilev is currently employed at Merck Patent GmbH, where he continues to contribute to the development of innovative therapies. His role at Merck allows him to collaborate with leading experts in the pharmaceutical industry, further enhancing his impact on cancer research.

Collaborations

Throughout his career, Lyubomir Vassilev has worked alongside esteemed colleagues such as Thomas Grombacher and Astrid Zimmermann. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Lyubomir Vassilev's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his importance in the field of medical research. His work continues to inspire advancements in therapeutic strategies for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…